Clinical Trial Update: Quantitative MRI in Assessing Disease in Patients With Brain Tumors [NA]

View source ↗

Summary

The trial evaluating quantitative MRI for assessing disease in patients with brain tumors (NCT02269111) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Brain Neoplasms

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Tumors Metastatic to Brain, Unspecified Adult Solid Tumor, Protocol Specific | NA | Status: TERMINATED